Picture supply: Getty Photos
The Various Funding Market (AIM) doesn’t have the perfect popularity. In addition to containing a variety of unprofitable companies which might be extra more likely to fold than increase, AIM shares might be very unstable. Nevertheless, I feel there are a minimum of just a few diamonds within the tough to think about shopping for.
Tanking share value
Bioventix (LSE: BVXP) is arguably one instance. Shares within the developer and business provider of monoclonal antibodies have tumbled over 40% within the final 12 months. Whereas a few of that is possible the results of broader market issues, lots is definitely right down to the corporate overstating revenues by £327,000 on account of a buyer error. In actuality, the agency’s precise revenues got here in beneath market expectations.
This information has clearly shaken confidence and pushed the inventory right down to a multi-year low.
Nevertheless, I reckon this might be a good time to consider loading up. As worrying as current kind has been, that is nonetheless an organization that reeks of high quality. Margins and returns on capital stay sky-high, thanks partly to having only a few workers. Whereas this has led to the shares buying and selling at a premium to the broader market, the present price-to-earnings (P/E) ratio of 16 is already considerably decrease than the agency’s five-year common of 27.
Half-year numbers — due on 24 March — shall be value studying. I reckon it’ll take solely a small chink of sunshine to get the shares transferring in the proper route once more.
Gross sales down
One other area of interest AIM-listed firm to think about that’s been battered is laser-guided gear producer Somero Enterprises (LSE: SOM). Its share value has fallen almost 20% in 2025 already.
So what’s gone flawed right here? Effectively, buyers have grow to be more and more involved in regards to the basic financial outlook, notably within the US (the place the corporate’s based mostly) which makes up three-quarters of gross sales. There’s an opportunity that issues will go from unhealthy to worse if rates of interest keep greater for longer and drive purchasers to delay buying the corporate’s cement-levelling tech.
Like Bioventix nevertheless, that is one other small-cap that scores constantly properly on high quality metrics. Supported by a powerful stability sheet and really skilled administration, Somero can also be a market chief in what it does. Though by no means assured, the dividend yield at the moment stands at a meaty 6.8% too.
Monster dividend yield
A ultimate AIM inventory that’s value pondering is base metals producer Central Asia Metals (LSE: CAML). Like the opposite two talked about right here, its shares have fallen in current instances, down 14% or so within the final 12 months.
Once more, a lot of this seems to be the results of basic geopolitical issues. That stated, demand for lead has been decrease. The corporate drills for this (and zinc) at its mine in North Macedonia. It additionally has copper operations in Kazakhstan.
On a extra constructive notice, the shares now yield an unbelievable 10% for FY25. Fairly whether or not buyers will see all of this money is open to debate if prices proceed to rise. Nevertheless, the overall dividend is predicted to be lined by revenue as issues stand. The inventory seems very low-cost too, altering arms at a P/E of simply seven for FY25.
Full-year numbers are due tomorrow (20 March). It is going to be attention-grabbing to see how present holders react.
